# Pfizer Inc. (PFE) — Q3-2012 Earnings Results

**Report date:** 2012-11-01 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q3-2012

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 1.29%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.53 | N/A | +1.34% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, no specific guidance was provided for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to shareholders.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Pfizer's earnings report showed a slight beat on EPS, which indicates some operational strength. However, the stock reacted negatively, declining by 1.29%. This may reflect investor concerns about the lack of revenue data and future guidance, leaving uncertainty about the company's growth trajectory.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q3-2012_